DarioHealth (DRIO) Stock Analysis: AI Score & Alternative Data
Alt-data signals are cooling for DarioHealth
Is DarioHealth a buy right now? The alternative data leans no. This DRIO stock analysis is built on the 25+ alternative data signals AltIndex tracks on DarioHealth every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 39/100: a Sell. The stock trades at $6.82 with a $71M market cap.
The 90-day pressure points: web traffic down 51.3% to 12K monthly visits, job postings down 16.7% to 10 open roles, and just 43% of employees report a positive business outlook. Stocks scoring below 40 have historically lagged the market.
DRIO’s broader alt-data profile also covers headcount (249 employees, according to LinkedIn), quarterly revenue ($10M), Facebook followers (71K), and app downloads (238). Every signal links to its own page with full history, the DRIO technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on DRIO is just below.
DarioHealth AI Stock Analysis
DarioHealth Corp. is a digital health company that focuses on providing health management solutions to chronic disease patients. The company's flagship product is a blood glucose monitoring system, but it has expanded its portfolio to include solutions for hypertension and weight management, among other chronic conditions.
Analysis generated September 3, 2026.
Recent DarioHealth Stock Alerts
|
DarioHealth | September 2 Price is up by 7.6% in the last 24h. |
|
DarioHealth | September 1 Price is down by -7.7% in the last 24h. |
|
DarioHealth | August 31 Price is up by 7.1% in the last 24h. |
|
DarioHealth | August 20 Price is up by 6.2% in the last 24h. |
DarioHealth Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 12K | 51.3% | |
| App Downloads | 238 | 67.9% | |
| Job Posts | 10 | 16.7% | |
| LinkedIn Employees | 249 | 0% | |
| Employee Recommend | 52 | 4.0% | |
| Business Outlook | 43 | 4.9% | |
| Sentiment | 50 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | 50.0% | |
| Stocktwits Mentions | 4 | 100.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 4K | 4.7% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 8K | 0% | |
| Instagram Followers | 8K | 0.7% | |
| Youtube Subscribers | 2K | 0% | |
| Facebook Followers | 71K | 0% | |
| Facebook Engagement | 143 | 5.9% |
About DarioHealth (DRIO)
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand.
| Price | $6.82 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $71M |
| Year Range | $6 – $17 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest DarioHealth News
View more → |
DarioHealth Corp. Q2 2026 Earnings Call SummaryAugust 11 - Moby.co |
DarioHealth Q2 Earnings Call HighlightsAugust 11 - MarketBeat |
|
 |
DarioHealth Reports Second Quarter 2026 Financial ResultsAugust 11 - PRNewswire |
 |
DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026August 3 - PRNewswire |
DarioHealth Q1 Earnings Call HighlightsMay 13 - Yahoo Entertainment |
|
See DarioHealth’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for DRIO, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEDarioHealth Earnings & Financial Performance
View all earnings →DarioHealth Insider Trading Activity
View all →| Matheis Dennis filed to sell 43,026 shares at $0.0. Jul 23 '26 |
| Nelson Steven Charles filed to sell 95,000 shares at $0.0. Aug 27 '25 |
| STERN ADAM K filed to sell 0 shares at $0.0. Jan 7 '25 |
| Nelson Steven Charles filed to sell 55,000 shares at $0.0. Nov 12 '24 |
| Nelson Steven Charles filed to sell 50,000 shares at $0.0. Sep 11 '24 |
DarioHealth Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to DarioHealth
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
ApollomicsAPLM |
$24.88 1.6% | $71M | 48 |
 |
Pliant TherapeuticsPLRX |
$1.15 1.3% | $72M | 56 |
 |
INmune BioINMB |
$2.46 2.0% | $70M | 47 |
 |
Spero TherapeuticsSPRO |
$1.17 1.7% | $69M | 47 |
 |
Heron TherapeuticsHRTX |
$0.33 4.9% | $66M | 40 |
Explore DarioHealth Data
Frequently Asked Questions: DarioHealth (DRIO)
DarioHealth has an AltIndex AI Score of 39/100 (Sell). The score reflects negative alternative data signals. All investments carry risk.
39/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of DarioHealth (DRIO) stock is $6.82 with a market cap of $71M.
As of today, DarioHealth’s PE (Price to Earnings) ratio is —.
View the latest DarioHealth insider transactions to see recent buying and selling activity by company executives and directors.
Check the DarioHealth congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The DRIO stock price chart above shows DarioHealth’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full DarioHealth technical analysis for RSI, moving averages, and more.
See the stocks similar to DarioHealth section on this page for companies in the same industry ranked by market cap and AI Score.
